Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

MacroGenics (MGNX)

$2.19 −$0.06 (−2.67%)

Day’s range
$1.93–$2.23
Volume
2.6M

MGNX price history

MGNX closed at $2.19 on Oct. 26, 2026. Over the past year, its daily close ranged from $1.33 on Dec. 8, 2025 to $4.86 on June 29, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $1 to $5, not from zero.
Data table: MGNX daily closes, the past year
MGNX daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$2.19
Oct. 23, 2026$2.25
Oct. 22, 2026$3.63
Oct. 21, 2026$3.59
Oct. 20, 2026$3.49
Oct. 19, 2026$3.33
Oct. 16, 2026$3.25
Oct. 15, 2026$3.37
Oct. 14, 2026$3.31
Oct. 13, 2026$3.42
Oct. 12, 2026$3.72
Oct. 9, 2026$3.74
Oct. 8, 2026$3.55
Oct. 7, 2026$3.55
Oct. 6, 2026$3.64
Oct. 5, 2026$3.77
Oct. 2, 2026$3.58
Oct. 1, 2026$3.60
Sept. 30, 2026$3.86
Sept. 29, 2026$3.77
Sept. 28, 2026$4.06
Sept. 25, 2026$3.74
Sept. 24, 2026$3.80
Sept. 23, 2026$3.80
Sept. 22, 2026$4.12
Sept. 21, 2026$4.12
Sept. 18, 2026$4.14
Sept. 17, 2026$4.13
Sept. 16, 2026$4.08
Sept. 15, 2026$4.04
Sept. 14, 2026$4.20
Sept. 11, 2026$4.00
Sept. 10, 2026$3.97
Sept. 9, 2026$4.11
Sept. 8, 2026$4.32
Sept. 4, 2026$4.40
Sept. 3, 2026$4.25
Sept. 2, 2026$4.32
Sept. 1, 2026$4.04
Aug. 31, 2026$3.99
Aug. 28, 2026$4.13
Aug. 27, 2026$4.08
Aug. 26, 2026$4.04
Aug. 25, 2026$4.17
Aug. 24, 2026$4.02
Aug. 21, 2026$4.10
Aug. 20, 2026$4.07
Aug. 19, 2026$4.17
Aug. 18, 2026$4.09
Aug. 17, 2026$4.06
Aug. 14, 2026$4.22
Aug. 13, 2026$4.08
Aug. 12, 2026$4.02
Aug. 11, 2026$3.92
Aug. 10, 2026$4.08
Aug. 7, 2026$4.04
Aug. 6, 2026$4.01
Aug. 5, 2026$3.90
Aug. 4, 2026$3.90
Aug. 3, 2026$3.82
July 31, 2026$3.69
July 30, 2026$3.78
July 29, 2026$3.67
July 28, 2026$3.85
July 27, 2026$4.00
July 24, 2026$3.70
July 23, 2026$4.01
July 22, 2026$4.30
July 21, 2026$4.54
July 20, 2026$4.32
July 17, 2026$4.49
July 16, 2026$4.12
July 15, 2026$4.32
July 14, 2026$4.29
July 13, 2026$4.50
July 10, 2026$4.33
July 9, 2026$4.57
July 8, 2026$4.66
July 7, 2026$4.75
July 6, 2026$4.57
July 2, 2026$4.71
July 1, 2026$4.62
June 30, 2026$4.62
June 29, 2026$4.86
June 26, 2026$4.81
June 25, 2026$4.66
June 24, 2026$4.78
June 23, 2026$4.69
June 22, 2026$4.58
June 18, 2026$4.13
June 17, 2026$3.96
June 16, 2026$3.88
June 15, 2026$4.13
June 12, 2026$3.96
June 11, 2026$4.01
June 10, 2026$3.87
June 9, 2026$3.91
June 8, 2026$3.88
June 5, 2026$3.91
June 4, 2026$4.25
June 3, 2026$4.20
June 2, 2026$4.05
June 1, 2026$4.14
May 29, 2026$4.16
May 28, 2026$4.21
May 27, 2026$4.38
May 26, 2026$4.47
May 22, 2026$4.53
May 21, 2026$4.24
May 20, 2026$4.46
May 19, 2026$4.52
May 18, 2026$4.35
May 15, 2026$4.25
May 14, 2026$4.16
May 13, 2026$3.45
May 12, 2026$3.52
May 11, 2026$2.95
May 8, 2026$3.00
May 7, 2026$2.94
May 6, 2026$3.01
May 5, 2026$3.15
May 4, 2026$3.20
May 1, 2026$3.13
April 30, 2026$3.08
April 29, 2026$2.94
April 28, 2026$3.01
April 27, 2026$3.05
April 24, 2026$3.19
April 23, 2026$3.18
April 22, 2026$3.42
April 21, 2026$3.47
April 20, 2026$3.48
April 17, 2026$3.46
April 16, 2026$3.41
April 15, 2026$3.52
April 14, 2026$3.49
April 13, 2026$3.47
April 10, 2026$3.60
April 9, 2026$3.44
April 8, 2026$3.45
April 7, 2026$3.35
April 6, 2026$3.18
April 2, 2026$3.07
April 1, 2026$2.90
March 31, 2026$2.89
March 30, 2026$2.76
March 27, 2026$2.93
March 26, 2026$3.18
March 25, 2026$3.17
March 24, 2026$2.73
March 23, 2026$2.92
March 20, 2026$2.86
March 19, 2026$2.90
March 18, 2026$2.98
March 17, 2026$3.08
March 16, 2026$3.10
March 13, 2026$3.00
March 12, 2026$3.12
March 11, 2026$3.34
March 10, 2026$3.43
March 9, 2026$2.36
March 6, 2026$2.23
March 5, 2026$2.14
March 4, 2026$2.08
March 3, 2026$1.90
March 2, 2026$1.94
Feb. 27, 2026$1.99
Feb. 26, 2026$1.98
Feb. 25, 2026$1.92
Feb. 24, 2026$1.73
Feb. 23, 2026$1.75
Feb. 20, 2026$1.70
Feb. 19, 2026$1.73
Feb. 18, 2026$1.70
Feb. 17, 2026$1.70
Feb. 13, 2026$1.71
Feb. 12, 2026$1.71
Feb. 11, 2026$1.72
Feb. 10, 2026$1.71
Feb. 9, 2026$1.80
Feb. 6, 2026$1.81
Feb. 5, 2026$1.70
Feb. 4, 2026$1.73
Feb. 3, 2026$1.75
Feb. 2, 2026$1.75
Jan. 30, 2026$1.83
Jan. 29, 2026$1.93
Jan. 28, 2026$1.80
Jan. 27, 2026$1.84
Jan. 26, 2026$1.83
Jan. 23, 2026$1.80
Jan. 22, 2026$1.76
Jan. 21, 2026$1.74
Jan. 20, 2026$1.75
Jan. 16, 2026$1.72
Jan. 15, 2026$1.70
Jan. 14, 2026$1.78
Jan. 13, 2026$1.75
Jan. 12, 2026$1.79
Jan. 9, 2026$1.83
Jan. 8, 2026$1.79
Jan. 7, 2026$1.81
Jan. 6, 2026$1.70
Jan. 5, 2026$1.72
Jan. 2, 2026$1.61
Dec. 31, 2025$1.61
Dec. 30, 2025$1.56
Dec. 29, 2025$1.60
Dec. 26, 2025$1.61
Dec. 24, 2025$1.62
Dec. 23, 2025$1.60
Dec. 22, 2025$1.59
Dec. 19, 2025$1.50
Dec. 18, 2025$1.57
Dec. 17, 2025$1.61
Dec. 16, 2025$1.35
Dec. 15, 2025$1.37
Dec. 12, 2025$1.40
Dec. 11, 2025$1.41
Dec. 10, 2025$1.40
Dec. 9, 2025$1.39
Dec. 8, 2025$1.33
Dec. 5, 2025$1.37
Dec. 4, 2025$1.38
Dec. 3, 2025$1.40
Dec. 2, 2025$1.42
Dec. 1, 2025$1.46
Nov. 28, 2025$1.53
Nov. 26, 2025$1.48
Nov. 25, 2025$1.45
Nov. 24, 2025$1.42
Nov. 21, 2025$1.40
Nov. 20, 2025$1.37
Nov. 19, 2025$1.42
Nov. 18, 2025$1.54
Nov. 17, 2025$1.51
Nov. 14, 2025$1.50
Nov. 13, 2025$1.60
Nov. 12, 2025$1.47
Nov. 11, 2025$1.52
Nov. 10, 2025$1.43
Nov. 7, 2025$1.37
Nov. 6, 2025$1.36
Nov. 5, 2025$1.44
Nov. 4, 2025$1.45
Nov. 3, 2025$1.58
Oct. 31, 2025$1.66
Oct. 30, 2025$1.60
Oct. 29, 2025$1.69
Oct. 28, 2025$1.85
Oct. 27, 2025$1.91

Key figures

52-week range
$1.33–$4.86Low Dec. 8, 2025; high June 29, 2026
Average daily volume
622,070Past 3 months
Market value
$139.5M
Dividend yield
—
From 52-week high
−54.94%

Price change

1 month
−41.44%
3 months
−40.81%
Year to date
+36.02%
1 year
+19.02%

$1,000 a year ago

$1,000 put into MGNX at the close on Oct. 24, 2025 would be worth $1,190.

Price only, dividends not included.

What Wall Street says about MGNX

In the past 90 days, Wall Street firms published 1 rating or price-target action on MGNX: 1 raised price target.

Rating and price-target actions on MGNX, past 90 days
ActionRating
B. Riley SecuritiesRaises targetBuy$9 to $11

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About MacroGenics, Inc.

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.

Headquarters
Rockville, Md.
Employees
293
Listed
Oct. 10, 2013
Sector
Health care
Industry
Pharmaceutical preparations

macrogenics.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about MGNX is on the site yet.

  • LLYEli Lilly & Co.
  • JNJJohnson & Johnson
  • ABBVABBVIE INC.
  • MRKMerck & Co., Inc.
  • ABTAbbott Laboratories
  • PFEPfizer Inc.